Nuwellis, Inc. (NUWE)
USD 0.84
(-12.5%)
USD 0.84
(-12.5%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.81 Million USD | 83.17% |
| 2022 | -16.75 Million USD | 27.25% |
| 2021 | -23.02 Million USD | -63.34% |
| 2020 | -14.09 Million USD | -1594.47% |
| 2019 | -832 Thousand USD | 84.82% |
| 2018 | -5.48 Million USD | 64.86% |
| 2017 | -15.59 Million USD | -1078.76% |
| 2016 | -1.32 Million USD | 91.36% |
| 2015 | -15.31 Million USD | 51.06% |
| 2014 | -31.29 Million USD | 42.2% |
| 2013 | -54.13 Million USD | -280.6% |
| 2012 | -14.22 Million USD | -116.73% |
| 2011 | -6.56 Million USD | -95.89% |
| 2010 | -3.35 Million USD | -106.14% |
| 2009 | -1.62 Million USD | 82.62% |
| 2008 | -9.34 Million USD | -42.82% |
| 2007 | -6.54 Million USD | -94.67% |
| 2006 | -3.36 Million USD | 44.01% |
| 2005 | -6 Million USD | -547.13% |
| 2004 | -928.13 Thousand USD | 20.77% |
| 2003 | -1.17 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -368.99 Thousand USD | 46.44% |
| 2024 Q1 | -689 Thousand USD | 75.56% |
| 2023 Q2 | -8.02 Million USD | 24.21% |
| 2023 Q4 | -2.81 Million USD | 31.41% |
| 2023 Q3 | -4.11 Million USD | 48.77% |
| 2023 FY | -2.81 Million USD | 83.17% |
| 2023 Q1 | -10.58 Million USD | 36.82% |
| 2022 FY | -16.75 Million USD | 27.25% |
| 2022 Q4 | -16.75 Million USD | -52.06% |
| 2022 Q2 | -14.25 Million USD | 21.51% |
| 2022 Q1 | -18.16 Million USD | 21.12% |
| 2022 Q3 | -11.01 Million USD | 22.73% |
| 2021 Q2 | -23.75 Million USD | 13.97% |
| 2021 Q1 | -27.6 Million USD | -95.84% |
| 2021 FY | -23.02 Million USD | -63.34% |
| 2021 Q4 | -23.02 Million USD | 18.52% |
| 2021 Q3 | -28.26 Million USD | -18.99% |
| 2020 Q4 | -14.09 Million USD | 19.69% |
| 2020 Q1 | -5.26 Million USD | -532.93% |
| 2020 FY | -14.09 Million USD | -1594.47% |
| 2020 Q2 | -7.4 Million USD | -40.56% |
| 2020 Q3 | -17.55 Million USD | -137.15% |
| 2019 Q2 | -6.86 Million USD | 37.07% |
| 2019 Q3 | -3.14 Million USD | 54.23% |
| 2019 Q4 | -832 Thousand USD | 73.54% |
| 2019 FY | -832 Thousand USD | 84.82% |
| 2019 Q1 | -10.91 Million USD | -99.18% |
| 2018 FY | -5.48 Million USD | 64.86% |
| 2018 Q4 | -5.48 Million USD | 33.35% |
| 2018 Q3 | -8.22 Million USD | -17.54% |
| 2018 Q2 | -6.99 Million USD | 33.41% |
| 2018 Q1 | -10.5 Million USD | 32.65% |
| 2017 Q4 | -15.59 Million USD | -520.57% |
| 2017 Q3 | -2.51 Million USD | 54.79% |
| 2017 FY | -15.59 Million USD | -1078.76% |
| 2017 Q2 | -5.55 Million USD | -234.62% |
| 2017 Q1 | -1.66 Million USD | -25.55% |
| 2016 Q4 | -1.32 Million USD | -67.05% |
| 2016 FY | -1.32 Million USD | 91.36% |
| 2016 Q2 | -6.14 Million USD | 36.44% |
| 2016 Q1 | -9.66 Million USD | 36.86% |
| 2016 Q3 | -792 Thousand USD | 87.11% |
| 2015 Q4 | -15.31 Million USD | 24.01% |
| 2015 FY | -15.31 Million USD | 51.06% |
| 2015 Q2 | -25.72 Million USD | 17.76% |
| 2015 Q3 | -20.15 Million USD | 21.66% |
| 2015 Q1 | -31.27 Million USD | 0.04% |
| 2014 Q1 | -47.42 Million USD | 12.4% |
| 2014 FY | -31.29 Million USD | 42.2% |
| 2014 Q4 | -31.29 Million USD | 14.44% |
| 2014 Q3 | -36.57 Million USD | 13.18% |
| 2014 Q2 | -42.12 Million USD | 11.17% |
| 2013 Q3 | -59.8 Million USD | -177.84% |
| 2013 Q2 | -21.52 Million USD | -96.23% |
| 2013 Q1 | -10.97 Million USD | 22.88% |
| 2013 FY | -54.13 Million USD | -280.6% |
| 2013 Q4 | -54.13 Million USD | 9.48% |
| 2012 Q4 | -14.22 Million USD | 18.47% |
| 2012 FY | -14.22 Million USD | -116.73% |
| 2012 Q2 | -1.77 Million USD | 53.76% |
| 2012 Q1 | -3.83 Million USD | 41.59% |
| 2012 Q3 | -17.44 Million USD | -884.54% |
| 2011 Q4 | -6.56 Million USD | 36.56% |
| 2011 Q2 | -6.43 Million USD | 0.0% |
| 2011 FY | -6.56 Million USD | -95.89% |
| 2011 Q3 | -10.34 Million USD | -60.71% |
| 2010 FY | -3.35 Million USD | -106.14% |
| 2010 Q4 | -12.24 Million USD | 0.0% |
| 2010 Q2 | -3.35 Million USD | 0.0% |
| 2009 Q4 | -6.98 Million USD | 0.0% |
| 2009 FY | -1.62 Million USD | 82.62% |
| 2009 Q2 | -1.62 Million USD | 0.0% |
| 2008 Q2 | -9.34 Million USD | 0.0% |
| 2008 Q4 | -4.02 Million USD | 0.0% |
| 2008 FY | -9.34 Million USD | -42.82% |
| 2007 FY | -6.54 Million USD | -94.67% |
| 2007 Q2 | -6.54 Million USD | 0.0% |
| 2007 Q4 | -7.18 Million USD | 0.0% |
| 2006 Q4 | -11.91 Million USD | 0.0% |
| 2006 Q2 | -3.36 Million USD | 0.0% |
| 2006 FY | -3.36 Million USD | 44.01% |
| 2005 FY | -6 Million USD | -547.13% |
| 2005 Q4 | -4.78 Million USD | 0.0% |
| 2005 Q2 | -6 Million USD | 0.0% |
| 2004 FY | -928.13 Thousand USD | 20.77% |
| 2004 Q4 | -8.69 Million USD | 0.0% |
| 2004 Q2 | -928.13 Thousand USD | 0.0% |
| 2003 FY | -1.17 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 110.409% |
| BrainsWay Ltd. | -10.32 Million USD | 72.684% |
| Cerus Corporation | 84.35 Million USD | 103.342% |
| Envoy Medical, Inc. | -3.81 Million USD | 26.088% |
| electroCore, Inc. | -9.95 Million USD | 71.683% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 44.995% |
| IceCure Medical Ltd | -9.93 Million USD | 71.623% |
| Inogen, Inc. | -103.56 Million USD | 97.278% |
| OrthoPediatrics Corp. | -9.26 Million USD | 69.58% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 22.576% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 78.476% |
| MaxCyte, Inc. | -27.76 Million USD | 89.846% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 45.135% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -389.608% |
| Orthofix Medical Inc. | 96.44 Million USD | 102.923% |
| PAVmed Inc | 29.08 Million USD | 109.692% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 83.358% |
| RxSight, Inc. | -6.68 Million USD | 57.799% |
| Sight Sciences, Inc. | -102.71 Million USD | 97.256% |
| SI-BONE, Inc. | 5.72 Million USD | 149.275% |
| TELA Bio, Inc. | -3.94 Million USD | 28.615% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 104.918% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 900.852% |
| Acutus Medical, Inc. | 12.27 Million USD | 122.958% |
| Talis Biomedical Corporation | -57.06 Million USD | 95.06% |
| Spectral AI, Inc. | -3.5 Million USD | 19.48% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 94.13% |
| CVRx, Inc. | -59.95 Million USD | 95.298% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 242.076% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 320.642% |
| Bioventus Inc. | 372.51 Million USD | 100.757% |
| Venus Concept Inc. | 74.3 Million USD | 103.794% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 72.314% |
| LivaNova PLC | 62.53 Million USD | 104.508% |
| 908 Devices Inc. | -115.09 Million USD | 97.551% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.879% |
| Nemaura Medical Inc. | 9.92 Million USD | 128.403% |
| NeuroPace, Inc. | 54.33 Million USD | 105.188% |
| LENSAR, Inc. | -18.31 Million USD | 84.606% |
| Apyx Medical Corporation | -5.15 Million USD | 45.273% |
| Cutera, Inc. | 288.3 Million USD | 100.978% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 137.512% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1175.954% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 93.568% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 69.355% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.201% |
| Axonics, Inc. | -77.19 Million USD | 96.348% |
| Outset Medical, Inc. | 67.67 Million USD | 104.165% |
| IRIDEX Corporation | -4.28 Million USD | 34.258% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.416% |
| IRadimed Corporation | -47.71 Million USD | 94.093% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 6.841% |
| INVO Bioscience, Inc. | 8.45 Million USD | 133.356% |
| Telesis Bio, Inc. | 32.63 Million USD | 108.638% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -12.664% |
| Varex Imaging Corporation | 316.9 Million USD | 100.89% |
| Quipt Home Medical Corp. | 81.73 Million USD | 103.449% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1.33% |
| Pulmonx Corporation | -42.36 Million USD | 93.345% |
| Dynatronics Corporation | 6.2 Million USD | 145.438% |
| Modular Medical, Inc. | -8.04 Million USD | 64.947% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 34.396% |
| Semler Scientific, Inc. | -57.13 Million USD | 95.066% |
| InMode Ltd. | -135.39 Million USD | 97.918% |
| Bruker Corporation | 891.3 Million USD | 100.316% |
| Cytosorbents Corporation | 4.18 Million USD | 167.408% |
| DexCom, Inc. | 2.02 Billion USD | 100.139% |
| Align Technology, Inc. | -840.47 Million USD | 99.665% |
| Viveve Medical, Inc. | -13.81 Million USD | 79.592% |
| ZimVie Inc. | 450.41 Million USD | 100.626% |
| Movano Inc. | -5.86 Million USD | 51.943% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 97.903% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -389.608% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 242.076% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.79% |
| Profound Medical Corp. | -18.17 Million USD | 84.493% |
| Insulet Corporation | 798.1 Million USD | 100.353% |
| enVVeno Medical Corporation | -2.21 Million USD | -27.096% |
| Surmodics, Inc. | -12.01 Million USD | 76.536% |
| iCAD, Inc. | -21.2 Million USD | 86.708% |
| Biotricity, Inc. | 23.09 Million USD | 112.207% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 103.01% |
| Aethlon Medical, Inc. | -4.5 Million USD | 37.379% |
| InspireMD, Inc. | -8.04 Million USD | 64.96% |
| PAVmed Inc. | 29.08 Million USD | 109.692% |
| BIOLASE, Inc. | 11.34 Million USD | 124.85% |
| Beyond Air, Inc. | 6.22 Million USD | 145.256% |
| FONAR Corporation | -14.66 Million USD | 80.778% |
| AxoGen, Inc. | 32.26 Million USD | 108.737% |
| Vivani Medical, Inc. | 42 Thousand USD | 6811.905% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 73.55% |
| Inari Medical, Inc. | -7.16 Million USD | 60.634% |
| UFP Technologies, Inc. | 40.77 Million USD | 106.914% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 191.865% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 40.918% |
| Tenon Medical, Inc. | -1.25 Million USD | -124.622% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 62.937% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 76.363% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.127% |
| Sintx Technologies, Inc. | 905 Thousand USD | 411.492% |
| NanoVibronix, Inc. | -3.27 Million USD | 14.002% |
| Quanterix Corporation | -132.95 Million USD | 97.88% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1.33% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 87.395% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.374% |
| TransMedics Group, Inc. | 121.13 Million USD | 102.327% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 89.232% |
| NeuroMetrix, Inc. | -1.49 Million USD | -89.059% |
| Hyperfine, Inc. | -75.61 Million USD | 96.272% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 101.852% |
| Biomerica, Inc. | -3.38 Million USD | 16.721% |
| Bone Biologics Corporation | -3.02 Million USD | 6.858% |
| AVITA Medical, Inc. | -26.23 Million USD | 89.253% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -53.339% |
| Silk Road Medical, Inc | 64.42 Million USD | 104.376% |